Frontiers in Cardiovascular Drug Discovery

by Atta-ur-Rahman

2020-12-30 12:35:25

Compare Price
Frontiers in Cardiovascular Drug Discovery is a book series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-th... Read more
Frontiers in Cardiovascular Drug Discovery is a book series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The book series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology. The fifth volume of the series covers the following topics: -The Lipid Hypothesis: From Resins to Proprotein Convertase Subtilisin/Kexin Type-9 Inhibitors-The Role of SGLT2i in the Prevention and Treatment of Heart Failure-Natural Products and Semi-Synthetic Compounds as Antithrombotics: A Review of the Last Ten Years (2009-2019)-Transient Receptor Potential Channels: Therapeutic Targets for Cardiometabolic Diseases?-Treatment of Raynaud’s Phenomenon-Traditional Medicine Based Cardiovascular Therapeutics-Cardiovascular Disease: A Systems Biology Approach Less

Book Details

Publication date October 2, 2020
Languageeng
ISBN9789811413247

Compare Prices

Store Availability Book Format Condition Price
eBooks.com In Stock PDF (encrypted) PDF (encrypted) Buy AUD 111.98
eBooks.comIn Stock
Format
PDF (encrypted)
Condition
PDF (encrypted)
Buy AUD 111.98
Available Discount
No Discount available

Join us and get access to all
your favourite books

Sign up for free and start exploring thousands of eBooks today.

Sign up for free